Precision Radiation Oncology

OCT 24, 2026 · JOURNAL ARTICLE

Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone

Precision Radiation Oncology

Abstract This planning study evaluated ultra‐hypofractionated three‐dose‐level radiotherapy for prostate cancer with a dominant intraprostatic lesion (DIL) abutting the urethral hi

SEP 12, 2026 · JOURNAL ARTICLE

C–X–C Motif Chemokine Receptor 4 (CXCR4)‐Targeted Biologically Guided Proton Spatially Fractionated Radiotherapy for Bulky Limited‐Stage Small Cell Lung Cancer

Precision Radiation Oncology

Abstract Background and Purpose To evaluate the feasibility and dosimetric safety of integrating C–X–C motif chemokine receptor 4 (CXCR4)‐targeted tracer 1 8 F‐AlF‐NOTA‐QHY‐04 posi

AUG 12, 2026 · JOURNAL ARTICLE

Normal tissue complication probability models of late cardiopulmonary toxicity following deep inspiration breath hold for breast cancer adjuvant radiotherapy

Precision Radiation Oncology

A well-designed comparative dosimetric study with NTCP modelling showing consistent reductions in predicted cardiopulmonary toxicity across two treatment regimens, but based on surrogate endpoints (dose and modelled complications) rather than clinical outcomes.

AUG 12, 2026 · JOURNAL ARTICLE

Robustness Evaluation of Physical versus Virtual Bolus for Breast VMAT Using RegGAN‐Based Synthetic CT

Precision Radiation Oncology

Small retrospective study (n=10) using synthetic CT to evaluate robustness of bolus strategies; demonstrates feasibility of the RegGAN approach but provides limited clinical evidence with marginal absolute differences and no hard clinical outcomes.